Peroni RN et al. |
Sex-linked differences in the vasorelaxant effects of anandamide in vascular mesenteric beds: role of oestrogens. |
2004 |
Eur. J. Pharmacol. |
pmid:15189776
|
Chen N et al. |
Inhibition by arachidonic acid and other fatty acids of dopamine uptake at the human dopamine transporter. |
2003 |
Eur. J. Pharmacol. |
pmid:14575792
|
Del Arco I et al. |
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. |
2002 |
Eur. J. Pharmacol. |
pmid:12409011
|
Nilsson O et al. |
The cannabinoid agonist WIN 55,212-2 inhibits TNF-alpha-induced neutrophil transmigration across ECV304 cells. |
2006 |
Eur. J. Pharmacol. |
pmid:16928371
|
de Lago E et al. |
In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. |
2004 |
Eur. J. Pharmacol. |
pmid:14744610
|
Moezi L et al. |
Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. |
2004 |
Eur. J. Pharmacol. |
pmid:14751408
|
Basavarajappa BS et al. |
Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. |
2003 |
Eur. J. Pharmacol. |
pmid:12679143
|
Wiley J et al. |
Discriminative stimulus effects of anandamide in rats. |
1995 |
Eur. J. Pharmacol. |
pmid:7781695
|
Wickens AP and Pertwee RG |
delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. |
1993 |
Eur. J. Pharmacol. |
pmid:8119321
|
Guindon J et al. |
Synergistic antinociceptive effects of anandamide, an endocannabinoid, and nonsteroidal anti-inflammatory drugs in peripheral tissue: a role for endogenous fatty-acid ethanolamides? |
2006 |
Eur. J. Pharmacol. |
pmid:17027744
|
Bondarenko AI et al. |
Direct activation of Ca and voltage-gated potassium channels of large conductance by anandamide in endothelial cells does not support the presence of endothelial atypical cannabinoid receptor. |
2017 |
Eur. J. Pharmacol. |
pmid:28327344
|
Baldassano S et al. |
Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle. |
2008 |
Eur. J. Pharmacol. |
pmid:18234188
|
Mechoulam R et al. |
Endocannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9831287
|
Romano MR and Lograno MD |
Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle. |
2013 |
Eur. J. Pharmacol. |
pmid:23396229
|
Ho WS |
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase. |
2013 |
Eur. J. Pharmacol. |
pmid:23340220
|
Barg J et al. |
Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. |
1995 |
Eur. J. Pharmacol. |
pmid:8749028
|
Stella N and Piomelli D |
Receptor-dependent formation of endogenous cannabinoids in cortical neurons. |
2001 |
Eur. J. Pharmacol. |
pmid:11513837
|
Randall MD and Kendall DA |
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. |
1997 |
Eur. J. Pharmacol. |
pmid:9369375
|
Mukherjee S et al. |
Species comparison and pharmacological characterization of rat and human CB2 cannabinoid receptors. |
2004 |
Eur. J. Pharmacol. |
pmid:15556131
|
Burkey TH et al. |
Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. |
1997 |
Eur. J. Pharmacol. |
pmid:9384246
|
López-Miranda V et al. |
Anandamide vehicles: a comparative study. |
2004 |
Eur. J. Pharmacol. |
pmid:15556148
|
Calignano A et al. |
Potentiation of anandamide hypotension by the transport inhibitor, AM404. |
1997 |
Eur. J. Pharmacol. |
pmid:9389389
|
Oz M et al. |
Endogenous cannabinoid anandamide directly inhibits voltage-dependent Ca(2+) fluxes in rabbit T-tubule membranes. |
2000 |
Eur. J. Pharmacol. |
pmid:10980258
|
Zheng Y et al. |
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system. |
2014 |
Eur. J. Pharmacol. |
pmid:24508383
|
Di Marzo V et al. |
Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. |
2001 |
Eur. J. Pharmacol. |
pmid:11408034
|
Wiley JL et al. |
Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. |
1998 |
Eur. J. Pharmacol. |
pmid:9760024
|
Lichtman AH et al. |
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs. |
1998 |
Eur. J. Pharmacol. |
pmid:9797029
|
Randall MD and Kendall DA |
Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery. |
1998 |
Eur. J. Pharmacol. |
pmid:9617751
|
Richardson JD et al. |
Antihyperalgesic effects of spinal cannabinoids. |
1998 |
Eur. J. Pharmacol. |
pmid:9600630
|
Haller VL et al. |
Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. |
2008 |
Eur. J. Pharmacol. |
pmid:18762181
|
Pertwee RG et al. |
Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. |
1995 |
Eur. J. Pharmacol. |
pmid:7713152
|
Gratzke C et al. |
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. |
2010 |
Eur. Urol. |
pmid:19147270
|
Prieto D |
Editorial comment on: localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity. |
2010 |
Eur. Urol. |
pmid:19147273
|
Wiley JL et al. |
A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. |
2004 |
Exp Clin Psychopharmacol |
pmid:15301634
|
Burkey RT and Nation JR |
(R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure. |
1997 |
Exp Clin Psychopharmacol |
pmid:9260067
|
Prestifilippo JP et al. |
Inhibition of salivary secretion by activation of cannabinoid receptors. |
2006 |
Exp. Biol. Med. (Maywood) |
pmid:16946411
|
De Petrocellis L et al. |
Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids. |
2007 |
Exp. Cell Res. |
pmid:17428469
|
Frampton G et al. |
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. |
2010 |
Exp. Cell Res. |
pmid:20347808
|
Grimaldi C et al. |
Anandamide inhibits adhesion and migration of breast cancer cells. |
2006 |
Exp. Cell Res. |
pmid:16343481
|
Jumpertz R et al. |
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide. |
2010 |
Exp. Clin. Endocrinol. Diabetes |
pmid:20429051
|
Matsuda S et al. |
Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. |
1997 |
Exp. Eye Res. |
pmid:9245900
|
Köse S et al. |
Human bone marrow mesenchymal stem cells secrete endocannabinoids that stimulate in vitro hematopoietic stem cell migration effectively comparable to beta-adrenergic stimulation. |
2018 |
Exp. Hematol. |
pmid:29030083
|
Venderova K et al. |
Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus. |
2005 |
Exp. Neurol. |
pmid:15899265
|
Hansen HS |
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain. |
2010 |
Exp. Neurol. |
pmid:20353771
|
Greco R et al. |
The endocannabinoid system and migraine. |
2010 |
Exp. Neurol. |
pmid:20353780
|
Bhaskaran MD and Smith BN |
Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. |
2010 |
Exp. Neurol. |
pmid:20144892
|
Kreutz S et al. |
Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. |
2007 |
Exp. Neurol. |
pmid:17010339
|
Bir LS and Ercan S |
Effects of intrathecal anandamide on somatosensory evoked responses in rats. |
2006 |
Exp. Neurol. |
pmid:16289169
|
Solbrig MV et al. |
A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. |
2005 |
Exp. Neurol. |
pmid:16022863
|
Morgese MG et al. |
Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB(1) and TRPV1 receptors. |
2007 |
Exp. Neurol. |
pmid:17900568
|